InvestorsHub Logo
icon url

justdafactss

11/07/21 10:17 AM

#192821 RE: Monroe1 #192820

The author "Biologics" is an idiot, article from last month---

Oct. 01, 2021 7:38 PM ET

For those investors looking to establish or add to a position, finding an opportunity might be difficult as we move to close out 2021. I expect the potential for an update from the Brazil trial or the highly anticipated partnership/collaboration announcement will prevent a large sell-off over the next couple of months. Perhaps a retest of the $1.60-$1.70 support will provide an opportunity to click the buy button..

https://seekingalpha.com/article/4458099-cytodyn-q4-is-crunch-time

Another duped CYDY koolaid drinker bites the dust.
icon url

ClosetInvestor

11/07/21 11:07 AM

#192824 RE: Monroe1 #192820

“Yes, a shareholders lawsuit against 13dhorned would cost money, but it is such a strong suit against 13d that many law firms would bring it on contingency. Then too the company at large would join in.”

If this is true, then why haven’t multiple lawsuits been filed? If this is true, why hasn’t CYDY sued the 13d for damages?

I can tell you why: NP is the root cause of all of the issues with CYDY and that’s why there are multiple lawsuits and investigations involving CYDY at that time. None involve the 13d.